Cargando…
Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens
Since the discovery of penicillin by Alexander Fleming in 1929 as a therapeutic agent against staphylococci, β-lactam antibiotics (BLAs) remained the most successful antibiotic classes against the majority of bacterial strains, reaching a percentage of 65% of all medical prescriptions. Unfortunately...
Autores principales: | Vrancianu, Corneliu Ovidiu, Gheorghe, Irina, Dobre, Elena-Georgiana, Barbu, Ilda Czobor, Cristian, Roxana Elena, Popa, Marcela, Lee, Sang Hee, Limban, Carmen, Vlad, Ilinca Margareta, Chifiriuc, Mariana Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697847/ https://www.ncbi.nlm.nih.gov/pubmed/33198306 http://dx.doi.org/10.3390/ijms21228527 |
Ejemplares similares
-
Present and Future Perspectives on Therapeutic Options for Carbapenemase-Producing Enterobacterales Infections
por: Vrancianu, Corneliu Ovidiu, et al.
Publicado: (2021) -
Antimicrobial Resistance in Romania: Updates on Gram-Negative ESCAPE Pathogens in the Clinical, Veterinary, and Aquatic Sectors
por: Barbu, Ilda Czobor, et al.
Publicado: (2023) -
Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii
por: Vrancianu, Corneliu Ovidiu, et al.
Publicado: (2020) -
The Challenge of Periprosthetic Joint Infection Diagnosis: From Current Methods to Emerging Biomarkers
por: Vrancianu, Corneliu Ovidiu, et al.
Publicado: (2023) -
Bacteriocins in the Era of Antibiotic Resistance: Rising to the Challenge
por: Gradisteanu Pircalabioru, Gratiela, et al.
Publicado: (2021)